Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Boston Scientific Corp., common-size consolidated balance sheet: liabilities and stockholders’ equity
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
- Current Debt Obligations
- The proportion of current debt obligations relative to total liabilities and stockholders’ equity showed a significant decrease from 10.73% in 2018 to almost negligible levels in 2020 at 0.04%, with minor fluctuations thereafter, remaining below 1% through 2022. This suggests a substantial reduction in short-term borrowing or refinancing into longer-term obligations.
- Accounts Payable
- Accounts payable as a percentage of total liabilities and equity increased gradually from 1.66% in 2018 to 2.65% in 2022, indicating a slight growth in amounts owed to suppliers or creditors over the period.
- Legal Reserves
- Legal reserves declined markedly from 3.39% in 2018 to 0.71% in 2022, reflecting reduced potential legal liabilities or settlements expected during the timeframe.
- Payroll and Related Liabilities
- These liabilities fluctuated moderately, decreasing from 3% in 2018 to a low of 2.21% in 2020, before rising slightly to 2.63% in 2021 and settling at 2.56% in 2022, showing relative stability with minor variation.
- Rebates
- The rebate liabilities remained fairly constant, holding near 1.08%-1.09% of total liabilities and equity from 2020 to 2022, indicating stable obligations in this category.
- Contingent Consideration
- Contingent consideration experienced a decline from 0.66% in 2018 to 0.08% in 2020, spiked to 0.9% in 2021, and then decreased again to 0.23% in 2022, demonstrating volatility possibly related to acquisition-related liabilities or earn-out payments.
- Other Current Liabilities and Accrued Expenses
- Other current liabilities percentage rose from 1.96% in 2018 to a peak of 3.11% in 2020 before dropping to 2.34% in 2022. Accrued expenses showed a downward trend from 10.7% in 2018 to 6.65% in 2022, indicating improved management or settlement of accrued obligations.
- Deferred Revenue
- Deferred revenue hovered around 0.45% to 0.68% in current liabilities and approximately 0.84% to 0.89% in long-term liabilities, showing slight increases indicative of more advance payments or contract liabilities over time.
- Licensing Arrangements
- Licensing arrangement liabilities decreased steadily from 0.64% in 2019 to 0.24% in 2022 within current liabilities, and similarly declined in long-term liabilities from 1.22% to 0.25%, suggesting diminishing obligations or completed agreements.
- Long-Term Debt
- Long-term debt rose from 22.87% in 2018 to a peak of 29.67% in 2020, then slightly declined to 27.46% in 2022, reflecting an increased reliance on long-term financing during the mid-period with some repayment or restructuring afterward.
- Deferred Tax Liabilities and Accrued Income Taxes
- Deferred tax liabilities showed a pronounced decline from 1.56% in 2018 to 0.44% in 2022, while accrued income taxes decreased from 3.52% to a low of 1.37% in 2021 before rising modestly to 1.84% in 2022, indicating fluctuating tax obligations and potential tax planning effects.
- Other Long-Term Liabilities
- Other long-term liabilities steadily declined from 8.96% in 2018 to 6.26% in 2022, indicating a reduction in miscellaneous long-term obligations.
- Total Liabilities
- Total liabilities as a percentage of total liabilities and equity decreased consistently from 58.45% in 2018 to 45.88% in 2022, illustrating a strengthening balance with reduced overall liabilities proportion.
- Stockholders' Equity
- Stockholders’ equity increased progressively from 41.55% in 2018 to 54.12% in 2022. This growth is supported by a notable reduction in accumulated deficit from -33.11% in 2018 to -2.31% in 2022 and relatively stable additional paid-in capital after a sizeable drop in 2019, signifying enhanced retained earnings and equity base.
- Treasury Stock
- Treasury stock as a negative component fluctuated between -8.18% and -5.62%, showing some buyback activity that was more significant earlier and slightly moderated/stabilized in later years.
- Overall Capital Structure
- The company’s financial structure exhibited a clear trend of deleveraging through lower total liabilities and higher equity proportions over the analyzed period. The reduction in current debt and accrued expenses alongside an increase in long-term debt and equity suggests a strategic shift to longer-term funding and balance sheet strengthening.